// App-Quantinova.ai

472 : Consolidation with Nivolumab and Brentuximab Vedotin after Autologous Hematopoietic Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma

Researchers

Presenter

  • Alex F. Herrera

Principal Investigators

  • Yago Nieto

  • Leona Holmberg

  • Patrick B. Johnston

  • Matthew Mei

  • Leslie Popplewell

  • Saro H. Armenian

  • Thai Cao

  • Len Farol

  • Firoozeh Sahebi

  • Ricardo Spielberger

  • Robert Chen

  • Auayporn P. Nademanee

  • Lacolle Peters

  • Neena Kennedy

  • Steven T. Rosen

  • Larry W. Kwak

  • Stephen J. Forman

  • Tatyana A. Feldman

Medical Centers

  • City of Hope, Duarte, CA

  • Department of Population Sciences, City of Hope, Duarte, CA

  • Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA

  • Division of Hematopathology, Department of Laboratory Medicine, Mayo Clinic, Rochester, MN

  • Gehr Family Center for Leukemia Research, City of Hope National Medical Center, Duarte, CA

  • Department of Population Sciences, City of Hope, Duarte, CA

  • Department of pathology, City of Hope National Medical Center, Duarte, CA.

  • Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA

  • The Judy and Bernard Briskin Center for Clinical Research, City of Hope, Duarte, CA

  • Autolus Limited, London, United Kingdom

  • Department of Hematology/HCT, City of Hope Nat'l. Med. Ctr., Duarte, CA

  • Beckman Research Institute at City of Hope, Duarte, CA

  • Deputy Director, City of Hope Comprehensive Cancer Center, Duarte, CA

  • Department of Hematology and Hematopietic Cell Transplantation, City of Hope, Duarte, CA

  • Hackensack University Medical Center, Oradell, NJ

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Hodgkin's Lymphoma

Biomarkers

  • Hematocrit

Drug/Treatment

  • Adcetris

  • Nivolumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved